With the Power to regulate prices, why not just regulate all drugs and medicines prices?

The Law recognizes competition as the primary instrument to attain the best price and best quality for drugs and medicines through generics promotion.  Competition also encourages innovation so we can have newer and better drugs.  However, in instances that effective competition is not attained, the Law and its IRR provides for regulations of prices as well as of all the other factors that contribute to high and inaccessible costs of drugs and medicines.  Thus, a balance between these two may be best for our countrymen to reap the full benefits of quality affordable medicines without compromising innovation for research for newer drugs.